Staar Surgical (STAA) Research & Development (2010 - 2026)

Staar Surgical's Research & Development history runs 17 years deep, the most recent figure standing at $24.5 million for Q2 2026.

• Quarterly Research & Development fell 9.04% year-over-year to $24.5 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $85.8 million (down 48.98% YoY) and the FY2026 annual result came in at $102.5 million, down 12.35% from the prior year.
• Research & Development was $24.5 million for Q2 2026 at Staar Surgical, down from $25.8 million in the prior quarter.
• Across five years, Research & Development topped out at $81.4 million in Q4 2024 and bottomed at -$44.8 million in Q4 2023.
• A 5-year average of $22.4 million and a median of $25.8 million in 2026 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2023 — Research & Development tumbled 284.78% — and 2024, when it jumped 281.93%.
• Staar Surgical's Research & Development stood at $24.2 million in 2022, then tumbled by 284.78% to -$44.8 million in 2023, then soared by 281.93% to $81.4 million in 2024, then tumbled by 88.69% to $9.2 million in 2025, then jumped by 166.14% to $24.5 million in 2026.
• Business Quant data shows STAA's Research & Development at $24.5 million in Q2 2026, $25.8 million in Q1 2026, and $9.2 million in Q3 2025.